XTL Biopharmaceuticals Ltd.

_________ false


	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	03/04/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-036504	Time of broadcast: 18:32 18:25:57

Complementary report for a report sent on date 02/04/2017 whose reference number was 2017-02-035052


Main details added/ completed:	(i) inserting outstanding ADS's and ordinary shares on the front cover and an exchange rate and date on page 67, (ii) removing repetitive language from Note 2 to the financial statements, and (iii) updating the exhibit index.

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
FORM 20-F-2016
Amended_20_F_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/03/2017
Address: HaCharoshet st 5 , Ra'anana 43656 Israel , Tel: 09-9557080 , Fax: 09-9519708
E-mail address: [email protected] Company site: www.xtlbio.com

Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD

Name of the Signatory: Kntor Ronen Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: abba hillel 12 , ramat gan 5250606 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: [email protected] 1

AI Terminal